Long-term changes of somatotrophic function induced by deprivation of growth hormone-releasing hormone during the fetal life of the rat.
We have studied the effects of intra-amniotic administration of an anti-GH-releasing hormone serum (GHRH-Ab) on day 16 of fetal life in the rat, when the ontogenetic development of the GHRH neuronal system occurs. Control animals received normal rabbit serum. Following delivery, body weight was monitored for the next 30 days as an index of somatic growth, and the following indices of somatotrophic function were determined: plasma and pituitary GH, pituitary GH mRNA, hypothalamic GHRH and somatostatin mRNA, and the in vivo GH responsiveness to GHRH. At birth, GHRH-Ab-treated rats had a body weight that was equivalent to that of control rats but, starting from postnatal day 6 up to day 30, they had a significantly reduced body weight. Pituitary weight, the absolute pituitary GH content and GH mRNA levels were lower in experimental compared with control rats, while pituitary GH concentrations were similar in the two groups, thus implying that there was a defect, not only in GH synthesis, but also in GH release. In agreement with this theory, basal GH levels and GHRH-stimulated GH secretion were reduced in GHRH-Ab-treated rats but, in contrast, hypothalamic regulation of GH secretion appeared to be working in these rats as they were still able to respond to the low plasma GH by increasing GHRH and decreasing somatostatin mRNA levels. These findings indicate that deprivation of GHRH during fetal life induces long-lasting changes of growth rate and somatotrophic function.(ABSTRACT TRUNCATED AT 250 WORDS)
Cella
S G
SG
Department of Pharmacology, Chemotherapy and Toxicology, University of Milan, Italy.
Locatelli
V
V
Broccia
M L
ML
Menegola
E
E
Giavini
E
E
De Gennaro Colonna
V
V
Torsello
A
A
Wehrenberg
W B
WB
Müller
E E
EE
D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D005314:Embryonic and Fetal Development / Q000502:physiology*; D005260:Female; D015870:Gene Expression / Q000502:physiology; D013006:Growth Hormone / Q000032:analysis / Q000235:genetics / Q000502:physiology*; D013007:Growth Hormone-Releasing Hormone / Q000172:deficiency* / Q000276:immunology / Q000494:pharmacology; D007031:Hypothalamus / Q000737:chemistry / Q000502:physiology*; D007106:Immune Sera / Q000008:administration & dosage; D010902:Pituitary Gland / Q000737:chemistry / Q000502:physiology*; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D013004:Somatostatin / Q000235:genetics
D007106:Immune Sera; D012333:RNA, Messenger; D013004:Somatostatin; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone